AQP4-IgG阳性NMOSD患者中不依赖复发的进展与复发相关恶化的患病率
该回顾性队列研究基于MSBase国际数据登记,纳入181例AQP4-IgG阳性NMOSD患者,中位随访4.5年。结果显示,4例(2.2%)出现5次不依赖复发的进展(PIRA),13例(7.2%)出现复发相关恶化(RAW)。作者认为PIRA在AQP4-IgG NMOSD中非常罕见。
要点
- AQP4-IgG阳性NMOSD患者中PIRA非常罕见,4例(2.2%)出现5次PIRA。
- 复发相关恶化(RAW)见于13例(7.2%)患者。
- 该多中心研究提示残疾累积仍主要与复发相关。
核心结论
- 该多中心研究强调,PIRA在AQP4-IgG阳性NMOSD中非常罕见。
研究设计与样本
- 回顾性队列研究,纳入MSBase国际数据登记中181例AQP4-IgG阳性NMOSD患者,要求至少有3次EDSS记录:基线、事件和6个月确认评分。
- 中位随访4.5年(Q1 1.7,Q3 7.8),女性占88.4%,中位发病年龄38.1岁。
主要发现
- 4例(2.2%)患者出现5次PIRA。
- 13例(7.2%)患者出现RAW。
临床怎么用
- 原文未据此给出推荐。
局限性
- 仅使用总体EDSS测量残疾。
- 未要求第二次EDSS评分来确认基线EDSS。
- 并非所有患者均有磁共振成像信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess the prevalence of progression independent of relapse activity (PIRA) and relapse-associated worsening (RAW) in AQP4-IgG NMOSD. METHODS: This was a retrospective cohort study of patients with AQP4-IgG NMOSD enrolled in the MSBase international data registry. Patients required a minimum of 3 recorded Expanded Disability Status Scale (EDSS) scores: baseline, event, and a 6-month confirmation score. Presence and absence of relapses between the baseline and event EDSS scores determined RAW and PIRA, respectively. Descriptive statistics were used to present the results. RESULTS: A total of 181 patients followed for a median of 4.5 years (Q1 1.7, Q3 7.8) were included. Most patients were female (88.4%), and the median age at disease onset was 38.1 years. Overall, 4 patients (2.2%) developed 5 incidences of PIRA and 13 patients developed RAW (7.2%). DISCUSSION: This multicenter study highlights that PIRA is very rare in AQP4-IgG NMOSD. Limitations of this study include the sole focus of overall EDSS to measure disability, lack of requirement for a second EDSS score to confirm baseline EDSS, and the absence of magnetic resonance imaging information for all patients.
引用
- Siriratnam P, Huda S, Van Der Walt A, et al. Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD. Neurology. 2024. PMID: 39561307. doi:10.1212/WNL.0000000000209940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。